Shelley Starck
NGM Biopharmaceuticals (United States)(US)
Publications by Year
Research Areas
Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Chronic Myeloid Leukemia Treatments, Macrophage Migration Inhibitory Factor, Natural product bioactivities and synthesis, Plant biochemistry and biosynthesis
Most-Cited Works
- → Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice(2020)276 cited
- → Dopaminergic Stimulation of Local Protein Synthesis Enhances Surface Expression of GluR1 and Synaptic Transmission in Hippocampal Neurons(2005)257 cited
- → (+)-Myristinin A, a Naturally Occurring DNA Polymerase β Inhibitor and Potent DNA-Damaging Agent(2005)97 cited
- → A General Approach to Detect Protein Expression In Vivo Using Fluorescent Puromycin Conjugates(2004)87 cited
- → The Fibronectin–ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid Cells(2021)62 cited
- → (+)-Myristinins A and D from Knema elegans, which Inhibit DNA Polymerase β and Cleave DNA(2005)55 cited
- → Naturally Occurring Alkylresorcinols That Mediate DNA Damage and Inhibit Its Repair(2000)41 cited
- → A Health Threat to Bystanders Living in the Homes of Smokers: How Smoke Toxins Deposited on Surfaces Can Cause Insulin Resistance(2016)36 cited
- → DNA Polymerase β Inhibitors from Baeckea gunniana(1999)36 cited
- → DNA Polymerase β Inhibitors from Sandoricum koetjape(1999)32 cited